Last Posted: Feb-05-2023 11:11:55

Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.
Jean-Laurent Casanova et al. The Journal of clinical investigation 2023 1 (3)
Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron.
Yuchen Wei et al. JAMA network open 2023 2 (2) e2254777
How quickly does COVID immunity fade? What scientists know.
Cassandra Willyard et al. Nature 2023 2
Global generalisability of AI-driven COVID-19 vaccination policies: a cross-sectional observational study
R Awasthi et al, MEDRXIV, February 2, 2023

Karampitsakos Theodoros, et al. Frontiers in medicine 2023 0 0. 1083264
Identification and development of a five-gene signature to improve the prediction of mechanical ventilator-free days for patients with COVID-19.
Ni J-X, et al. European review for medical and pharmacological sciences 2023 0 0. (2) 805-817
Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity.
Hanifa Muhammad, et al. Frontiers in cell and developmental biology 2023 0 0. 940863
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant.
Uriu Keiya, et al. The Lancet. Infectious diseases 2023 0 0.
COVID-19 booster vaccination coverage among adults, children and adolescents and reasons for non-receipt, United States.
Nguyen Kimberly H, et al. American journal of infection control 2023 0 0.
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics.
Arman Kaifee, et al. Gene 2023 0 0. 147232
An overview of current accomplishments and gaps of COVID-19 vaccine platforms and considerations for next generation vaccines.
Kale Akanksha, et al. Journal of pharmaceutical sciences 2023 0 0.
A Comparative study on epidemiological characteristics, transmissibility, and pathogenicity of three COVID-19 outbreaks caused by different variants.
Liu Chan, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2023 0 0.
Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.
Varea-Jiménez Elena, et al. Enfermedades infecciosas y microbiologia clinica (English ed.) 2023 0 0.
APOE4: A Culprit for the Vulnerability of COVID-19 in Alzheimer's Patients.
Goyal Ahsas, et al. Current neurovascular research 2023 0 0.
All Latest
About COVID-19 GPH
Site Citation:
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.


Sign up Email Alert
Special Topics
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
Mechanism | Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action |
Transmission | Characteristics and modes of covid-19 transmissions, such as human-to-human |
Diagnosis | Disease assessment through symptoms, test results, and radiological features |
Prevention | Prevention, control, response and management strategies |
Case Report | Descriptions of specific patient cases |
Forecasting | Modelling and estimating the trend of covid-19 spread |
Health Equity | Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others. |
Vaccine | Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages |
Variant | Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page |
Surveillance | Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker |
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Genomics and Precision Public Health to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 05, 2023
- Content source: